Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation (Tables)

v3.25.2
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees

The following table summarizes the stock-based compensation expense for stock options granted to employees and non-employees:

 

 

 

Three Months Ended June 30,

 

 

Six months ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Research and development

 

$

1,655,836

 

*

$

(7,706

)

 

$

2,109,022

 

*

$

10,224

 

Selling, general and administrative

 

 

2,552,906

 

 

 

38,403

 

 

 

4,141,916

 

 

 

73,907

 

Total stock-based compensation expense

 

$

4,208,742

 

 

$

30,697

 

 

$

6,250,938

 

 

$

84,131

 

*Includes $0.7 million and $1.0 million for the three and six months ended June 30, 2025, respectively, related to the restricted stock awards issued in connection with the acquisition of CorHepta.